Literature DB >> 19369080

Effects of detergents on the West Nile virus protease activity.

Manolya D Ezgimen1, Niklaus H Mueller, Tadahisa Teramoto, R Padmanabhan.   

Abstract

Detergents such as Triton X-100 are often used in drug discovery research to weed out small molecule promiscuous and non-specific inhibitors which act by aggregation in solution and undesirable precipitation in aqueous assay buffers. We evaluated the effects of commonly used detergents, Triton X-100, Tween-20, Nonidet-40 (NP-40), Brij-35, and CHAPS, on the enzymatic activity of West Nile virus (WNV) protease. Unexpectedly, Triton X-100, Tween-20, and NP-40 showed an enhancement of in vitro WNV protease activity from 2 to 2.5-fold depending on the detergent and its concentration. On the other hand, Brij-35, at 0.001% enhanced the protease activity by 1.5-fold and CHAPS had the least enhancing effect. The kinetic analysis showed that the increase in protease activity by Triton X-100 was dose-dependent. Furthermore, at Triton X-100 and Tween-20 concentrations higher than 0.001%, the inhibition of compound B, one of the lead compounds against WNV protease identified in a high throughput screen (IC(50) value of 5.7+/-2.5 microM), was reversed. However, in the presence of CHAPS, compound B still showed good inhibition of WNV protease. Our results, taken together, indicate that nonionic detergents, Triton X-100, Tween, and NP-40 are unsuitable for the purpose of discrimination of true versus promiscuous inhibitors of WNV protease in high throughput assays.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369080      PMCID: PMC2817951          DOI: 10.1016/j.bmc.2009.03.050

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  41 in total

Review 1.  High-throughput screening for kinase inhibitors.

Authors:  Oliver von Ahsen; Ulf Bömer
Journal:  Chembiochem       Date:  2005-03       Impact factor: 3.164

2.  Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures.

Authors:  Brian Y Feng; Brian K Shoichet
Journal:  J Med Chem       Date:  2006-04-06       Impact factor: 7.446

3.  A detergent-based assay for the detection of promiscuous inhibitors.

Authors:  Brian Y Feng; Brian K Shoichet
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  High-throughput assays for promiscuous inhibitors.

Authors:  Brian Y Feng; Anang Shelat; Thompson N Doman; R Kip Guy; Brian K Shoichet
Journal:  Nat Chem Biol       Date:  2005-07-03       Impact factor: 15.040

5.  Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B.

Authors:  S Clum; K E Ebner; R Padmanabhan
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Indolizine 1-sulfonates as potent inhibitors of 15-lipoxygenase from soybeans.

Authors:  Solomon Teklu; Lise-Lotte Gundersen; Tove Larsen; Karl E Malterud; Frode Rise
Journal:  Bioorg Med Chem       Date:  2005-05-02       Impact factor: 3.641

7.  Characterization of the West Nile virus protease substrate specificity and inhibitors.

Authors:  Niklaus H Mueller; Changsuek Yon; Vannakambadi K Ganesh; R Padmanabhan
Journal:  Int J Biochem Cell Biol       Date:  2006-11-23       Impact factor: 5.085

8.  Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease.

Authors:  Aloke K Bera; Richard J Kuhn; Janet L Smith
Journal:  J Biol Chem       Date:  2007-03-02       Impact factor: 5.157

Review 9.  Dengue/dengue haemorrhagic fever: history and current status.

Authors:  Duane J Gubler
Journal:  Novartis Found Symp       Date:  2006

10.  Recombinant dengue virus type 1 NS3 protein exhibits specific viral RNA binding and NTPase activity regulated by the NS5 protein.

Authors:  T Cui; R J Sugrue; Q Xu; A K Lee; Y C Chan; J Fu
Journal:  Virology       Date:  1998-07-05       Impact factor: 3.616

View more
  7 in total

1.  Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.

Authors:  Lynne Cregar-Hernandez; Guan-Sheng Jiao; Alan T Johnson; Axel T Lehrer; Teri Ann S Wong; Stephen A Margosiak
Journal:  Antivir Chem Chemother       Date:  2011-05-12

2.  Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.

Authors:  Kok-Chuan Tiew; Dengfeng Dou; Tadahisa Teramoto; Huiguo Lai; Kevin R Alliston; Gerald H Lushington; R Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2011-12-30       Impact factor: 3.641

3.  Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module.

Authors:  Nobuo Maita; Takahiro Tsukimura; Takako Taniguchi; Seiji Saito; Kazuki Ohno; Hisaaki Taniguchi; Hitoshi Sakuraba
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

4.  Nucleosomes structure and dynamics: effect of CHAPS.

Authors:  Irina Menshikova; Evgeny Menshikov; Nina Filenko; Yuri L Lyubchenko
Journal:  Int J Biochem Mol Biol       Date:  2011-03-07

5.  High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.

Authors:  Anuradha Balasubramanian; Mark Manzano; Tadahisa Teramoto; Rajendra Pilankatta; Radhakrishnan Padmanabhan
Journal:  Antiviral Res       Date:  2016-08-15       Impact factor: 5.970

6.  NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex.

Authors:  Young Mee Kim; Shovanlal Gayen; CongBao Kang; Joma Joy; Qiwei Huang; Angela Shuyi Chen; John Liang Kuan Wee; Melgious Jin Yan Ang; Huichang Annie Lim; Alvin W Hung; Rong Li; Christian G Noble; Le Tian Lee; Andy Yip; Qing-Yin Wang; Cheng San Brian Chia; Jeffrey Hill; Pei-Yong Shi; Thomas H Keller
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

7.  Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.

Authors:  Sudagar S Gurcha; Veeraraghavan Usha; Jonathan A G Cox; Klaus Fütterer; Katherine A Abrahams; Apoorva Bhatt; Luke J Alderwick; Robert C Reynolds; Nicholas J Loman; VijayaShankar Nataraj; Carlos Alemparte; David Barros; Adrian J Lloyd; Lluis Ballell; Judith V Hobrath; Gurdyal S Besra
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.